相关实验视频

Updated: Jun 25, 2025

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on: April 1, 2015

临床相关的GABARAP缺陷在多发性骨髓瘤中取消了博特佐米布诱导的免疫细胞死亡

Liwei Zhao^1,2, Zhe Shen^1,2, Guido Kroemer^1,2,3

¹Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université de Paris Cité, Sorbonne Université, Paris, France.

|May 30, 2024

概括

对GABA类型A受体相关蛋白 (GABARAP) 的下调会损害多发性骨髓瘤细胞中的自和卡尔雷蒂库林暴露. 这种缺陷防止癌细胞在用博特佐米布治疗时经历免疫细胞死亡.

科学领域:

在瘤学瘤学.
细胞生物学细胞生物学
免疫学免疫学免疫学

背景情况:

多发性骨髓瘤 (MM) 是血细胞的癌症.
博尔特佐米布是一种蛋白酶体抑制剂,用于治疗MM.
免疫性细胞死亡 (ICD) 是一种引起抗瘤免疫反应的细胞死亡形式.

研究的目的:

研究GABA类型A受体相关蛋白 (GABARAP) 在MM细胞对博特佐米布的反应中的作用.
为了确定GABARAP下调对自和calreticulin暴露的影响.
了解GABARAP缺乏对接受博特佐米布治疗的MM细胞免疫性的影响.

主要方法:

在MM细胞中的GABARAP表达的分析.
在GABARAP缺少的MM细胞中评估自流量.
对MM细胞的表面calreticulin暴露的测量.
免疫性细胞死亡标志物的评估.

主要成果:

高风险,预后不佳的MM的特点是GABARAP下调.
加巴拉普缺乏导致缺陷的自.
降低GABARAP的调节会影响表面calreticulin的暴露.
在博特佐米布治疗后,GABARAP缺陷的MM细胞无法经历免疫细胞死亡.

结论:

在MM细胞中,GABARAP在调解自和卡莱蒂库林暴露方面发挥着至关重要的作用.
GABARAP的下调与对博尔特佐米布诱导的免疫细胞死亡的抵抗有关.
向GABARAP可能是一种治疗策略,用于增强MM中博特佐米布的疗效.

关键词:

免疫治疗是一种免疫疗法.自自是自的过程.与危险相关的分子模式发酵细胞的形成发酵细胞的形成

更多相关视频

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

The Intrinsic Apoptotic Pathway

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...